Sort
21,453 grants matching “tuberculosis”
BUILDING GLOBAL CAPACITY FOR DIAGNOSTIC TESTING OF TUBERCULOSIS, MALARIA AND HIV
$2,865,000Heidi Albert · Foundation/Innovative New Diagnostics · U2G · FY2014 · PS
Mechanisms of CD4 T cell help to myeloid cells in tuberculosis
$2,863,501Tyler Dallas Bold · University Of Minnesota · R01 · FY2025 · AI
Durban International Clinical Trials Unit
$2,855,468Umesh G Lalloo · University Of Kwazulu-Natal · U01 · FY2009 · AI
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$2,849,260L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2009 · PS
International Center for Excellence in Research (ICER) in Uganda: Impact of ARVs
$2,848,611Steven Reynolds · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Immunopathogenic Mechanisms of Human Immunodeficiency Virus (HIV) Disease
$2,846,103Irini Sereti · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Cellular Immunology Core Laboratory
$2,839,188Amitinder Kaur · Tulane University Of Louisiana · N01 · FY2024 · AI
Metabolic factors that control the spectrum of human tuberculosis
$2,836,968David Branch Moody · Brigham And Women'S Hospital · U19 · FY2016 · AI
COLLABORATIVE AIDS PROGRAMME OF RESEARCH IN SOUTH AFRICA
$2,832,650Salim S Abdool Karim · University Of Kwazulu-Natal · U19 · FY2006 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit
$2,828,231Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2019 · AI
Wits HIV Research Group CLINICAL TRIAL UNIT (CTU) reapplication
$2,826,477Ian Matthias Sanne · Wits Health Consortium (Pty), Ltd · UM1 · FY2022 · AI
TUBERCULOSIS ELIMINATION & LABORATORY
$2,826,414Michelle Conner · Georgia Department Of Community Health · U52 · FY2010 · PS
Role of antigen-specific T cell responses in the control of TB
$2,826,310Henry M Blumberg · Emory University · U19 · FY2020 · AI
Scientific Core - Compound Optimization and Prioritization.
$2,822,282Anna Upton · Global Alliance For Tb Drug Development · U19 · FY2023 · AI
Systems Genetics of Tuberculosis
$2,817,044Christopher M Sassetti · Univ Of Massachusetts Med Sch Worcester · P01 · FY2024 · AI
TB Clinical Diagnostics Research Consortium
$2,816,254Jerrold J. Ellner · Johns Hopkins University · N01 · FY2013 · AI
Epidemiology and transmission dynamics of MDR/XDR tuberculosis
$2,815,208Megan B Murray · Brigham And Women'S Hospital · U19 · FY2009 · AI
Development of Adjuvant with Vaccines for Tuberculosis and Shigellosis
$2,814,783Kathlenn Kozar · Tulane University · N01 · FY2016 · AI
CENTERS FOR DISEASE CONTROL AND PREVENTION, TUBERCULOSIS ELIMINATION, LABORATORY
$2,801,956L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2010 · PS
TUBERCULOSIS CONTROL PROGRAM AND AIDS
$2,799,251L Masae Kawamura · San Francisco Department Of Public Health · U52 · FY2008 · PS
LOC: HIV Vaccine Trials Network
$2,797,660Lawrence Corey · Fred Hutchinson Cancer Center · UM1 · FY2024 · AI
Identification of novel Th17 inducing CTLR agonists for vaccines against mycobacterium tuberculosis
$2,796,602Jay Evans · University Of Montana · N01 · FY2017 · AI
Vaccine and Treatment Evaluation Unit at Saint Louis University
$2,792,722Daniel F. Hoft · Saint Louis University · UM1 · FY2025 · AI
MIDAS Center for Communicable Disease Dynamics
$2,791,232Marc Lipsitch · Harvard School Of Public Health · U54 · FY2013 · GM
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$2,790,912Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2021 · AI